116 related articles for article (PubMed ID: 9207923)
1. Human umbilical vein endothelial cells express high affinity receptors for factor Xa.
Bono F; Herault JP; Avril C; Schaeffer P; Lormeau JC; Herbert JM
J Cell Physiol; 1997 Jul; 172(1):36-43. PubMed ID: 9207923
[TBL] [Abstract][Full Text] [Related]
2. Effector protease receptor 1 mediates the mitogenic activity of factor Xa for vascular smooth muscle cells in vitro and in vivo.
Herbert J; Bono F; Herault J; Avril C; Dol F; Mares A; Schaeffer P
J Clin Invest; 1998 Mar; 101(5):993-1000. PubMed ID: 9486969
[TBL] [Abstract][Full Text] [Related]
3. Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells.
Senden NH; Jeunhomme TM; Heemskerk JW; Wagenvoord R; van't Veer C; Hemker HC; Buurman WA
J Immunol; 1998 Oct; 161(8):4318-24. PubMed ID: 9780208
[TBL] [Abstract][Full Text] [Related]
4. Activation-dependent exposure of the inter-EGF sequence Leu83-Leu88 in factor Xa mediates ligand binding to effector cell protease receptor-1.
Ambrosini G; Plescia J; Chu KC; High KA; Altieri DC
J Biol Chem; 1997 Mar; 272(13):8340-5. PubMed ID: 9079657
[TBL] [Abstract][Full Text] [Related]
5. Activation of human vascular endothelial cells by factor Xa: effect of specific inhibitors.
Herault JP; Bono F; Avril C; Schaeffer P; Herbert JM
Biochem Pharmacol; 1999 Mar; 57(6):603-10. PubMed ID: 10037444
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by human thrombomodulin of factor Xa-mediated cleavage of prothrombin.
Thompson EA; Salem HH
J Clin Invest; 1986 Jul; 78(1):13-7. PubMed ID: 3013935
[TBL] [Abstract][Full Text] [Related]
7. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
Warn-Cramer BJ; Almus FE; Rapaport SI
Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
[TBL] [Abstract][Full Text] [Related]
8. Factor XI assembly and activation on human umbilical vein endothelial cells in culture.
Shariat-Madar Z; Mahdi F; Schmaier AH
Thromb Haemost; 2001 Mar; 85(3):544-51. PubMed ID: 11307829
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody specific for tissue factor pathway inhibitor-factor Xa complex: its characterization and application to plasmas from patients with disseminated intravascular coagulation and pre-disseminated intravascular coagulation.
Ohkura N; Soe G; Kohno I; Kumeda K; Wada H; Kamikubo Y; Shiku H; Kato H
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):309-19. PubMed ID: 10493212
[TBL] [Abstract][Full Text] [Related]
10. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: its catalytic efficiency is similar to that of prothrombinase complex on platelets.
Sugo T; Nakamikawa C; Tanabe S; Matsuda M
J Biochem; 1995 Feb; 117(2):244-50. PubMed ID: 7608107
[TBL] [Abstract][Full Text] [Related]
11. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
12. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
Camire RM; Kalafatis M; Tracy PB
Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
[TBL] [Abstract][Full Text] [Related]
13. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of effector cell protease receptor-1, a novel cell surface receptor for the protease factor Xa.
Altieri DC
J Biol Chem; 1994 Feb; 269(5):3139-42. PubMed ID: 8106347
[TBL] [Abstract][Full Text] [Related]
15. Interaction of thrombin and factor Xa with bovine vascular endothelial cells, smooth muscle cells and rat hepatoma cells.
Dryjski M; Kuo BS; Bjornsson TD
Thromb Haemost; 1988 Oct; 60(2):148-52. PubMed ID: 3217915
[TBL] [Abstract][Full Text] [Related]
16. Transient high affinity binding of tissue factor pathway inhibitor-factor Xa complexes to negatively charged phospholipid membranes.
Willems GM; Janssen MP; Salemink I; Wun TC; Lindhout T
Biochemistry; 1998 Mar; 37(10):3321-8. PubMed ID: 9521652
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GROalpha-induced human endothelial cell proliferation by the alpha-chemokine inhibitor antileukinate.
Fujisawa N; Hayashi S; Kurdowska A; Carr FK; Miller EJ
Cytokine; 1999 Mar; 11(3):231-8. PubMed ID: 10209071
[TBL] [Abstract][Full Text] [Related]
18. Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2.
Bono F; Schaeffer P; Hérault JP; Michaux C; Nestor AL; Guillemot JC; Herbert JM
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):E107-12. PubMed ID: 11073863
[TBL] [Abstract][Full Text] [Related]
19. Factor Xa acts as a PDGF-independent mitogen in human vascular smooth muscle cells.
Bretschneider E; Braun M; Fischer A; Wittpoth M; Glusa E; Schrör K
Thromb Haemost; 2000 Sep; 84(3):499-505. PubMed ID: 11019978
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of two direct and indirect factor Xa inhibitors on free and clot-bound prothrombinase.
Hérault JP; Bernat A; Pflieger AM; Lormeau JC; Herbert JM
J Pharmacol Exp Ther; 1997 Oct; 283(1):16-22. PubMed ID: 9336303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
